Biopharma Money on the Move: December 16-22 – BioSpace

Related Articles:

• Monthy research review – December 2019 December 30, 2019   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during December 2019. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Other news Review…
• Monthly Research Review – December 2020 December 31, 2020   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during December 2020. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Conferences/lectures Other news…
• I-Mab Biopharma and Jiangsu Nhwa Pharmaceutical Announce Strategic Collaboration Agreement with Biodextris and a Boston-Based, Leading Academic Medical Center - BioSpace April 8, 2019 I-Mab Biopharma and Jiangsu Nhwa Pharmaceutical Announce Strategic Collaboration Agreement with Biodextris and a Boston-Based, Leading Academic Medical Center  BioSpacePublished: Apr 08, 2019. BOSTON, April 7, 2019 /PRNewswire/ -- I-Mab Biopharma (I-Mab), a clinical stage biotech company based in Shanghai with an ...
• GBS Global Biopharma and National Research Council of Canada Begin Preclinical Studies on Chronic-Neuropathic Pain Therapies - BioSpace May 28, 2019 GBS Global Biopharma and National Research Council of Canada Begin Preclinical Studies on Chronic-Neuropathic Pain Therapies  BioSpacePublished: May 28, 2019. GBS Global Biopharma's proprietary neuropathic pain therapies are orally-delivered, time-released nanoparticles containing myrcene ...
• Information about donations and receipts during December December 16, 2020 Topics I’ve already donated: What is the status of my receipt? In response to the provincially mandated lockdown in Toronto, home of most of our data processing and receipting operations, the issuing of charitable tax receipts may be delayed. Like you, we put the needs of people with Parkinson’s first and prioritize the safety of our staff. While we are…
• 2019: Year in review December 31, 2019   In this end-of-year post, we review the Parkinson’s research that caught our attention at SoPD HQ in 2019. Month-by-month we will briefly discuss some of the major pieces of research/announcements that have defined the year and advanced our understanding of Parkinson’s. The list is based on nothing more than the author’s personal opinion – apologies to any researchers who…
• GB Sciences Launches Global Expansion in Canada with GBS Global Biopharma, Inc. - BioSpace March 19, 2019 GB Sciences Launches Global Expansion in Canada with GBS Global Biopharma, Inc.  BioSpacePublished: Mar 19, 2019. Expedites innovative cannabinoid medicine program, covering 60 disease and health conditions including Parkinson's Disease, ...
• For Sale (Or Not): 10 Top Takeover Targets in the Biopharma Industry - BioSpace September 10, 2019 For Sale (Or Not): 10 Top Takeover Targets in the Biopharma Industry  BioSpaceThere are high hopes for more M&A in the industry for the remainder of the year. Here's a look at the 10 top takeover targets.
• XWPharma Names Michael M. Morrissey, PhD to Board of DirectorsAppointment Adds Senior Biopharma Operational Expertise to Board Oversight as Company Advances its Pipeline of Novel CNS Therapeutics in Research and Clinical Development - BioSpace December 16, 2020 XWPharma Names Michael M. Morrissey, PhD to Board of DirectorsAppointment Adds Senior Biopharma Operational Expertise to Board Oversight as Company Advances its Pipeline of Novel CNS Therapeutics in Research and Clinical Development  BioSpace
• 2020: Year in Review January 1, 2021 # # # # In this end-of-year post, we review the Parkinson’s research that caught our attention at SoPD HQ in 2020. Month-by-month we will briefly discuss some of the major pieces of research/ announcements that have defined the year and advanced our understanding of Parkinson’s. The list is based on nothing more than the author’s personal opinion – apologies…
• I-Mab Biopharma and Jiangsu Nhwa Pharmaceutical Announce Strategic Collaboration Agreement with Biodextris and a Boston-Based, Leading Academic Medical Center - PRNewswire April 8, 2019 I-Mab Biopharma and Jiangsu Nhwa Pharmaceutical Announce Strategic Collaboration Agreement with Biodextris and a Boston-Based, Leading Academic Medical Center  PRNewswireBOSTON, April 7, 2019 /PRNewswire/ -- I-Mab Biopharma (I-Mab), a clinical stage biotech company based in Shanghai with an exclusive focus on the ...
• I-Mab Biopharma and Jiangsu Nhwa Pharmaceutical Announce Strategic Collaboration Agreement with Biodextris and a Boston-Based, Leading Academic Medical Center - P&T Community April 8, 2019 I-Mab Biopharma and Jiangsu Nhwa Pharmaceutical Announce Strategic Collaboration Agreement with Biodextris and a Boston-Based, Leading Academic Medical Center  P&T CommunityBOSTON, April 7, 2019 /PRNewswire/ -- I-Mab Biopharma (I-Mab), a clinical stage biotech company based in Shanghai with an exclusive focus on the ...
• Trial Milestone Reached; UK-Based Biopharma Gets $15 Million - Streetwise Reports May 8, 2019 Trial Milestone Reached; UK-Based Biopharma Gets $15 Million  Streetwise ReportsThe first patient has been treated in the second cohort of a Phase 2 study of a gene therapy targeting Parkinson's disease, explained an H.C. Wainwright & Co.
• Bayer acquires remaining shares of BlueRock - BioPharma-Reporter.com August 13, 2019 Bayer acquires remaining shares of BlueRock  BioPharma-Reporter.comBayer to fully acquire BlueRock Therapeutics' to build its cell therapy pipeline based on the latter's induced pluripotent stem cell platform. BlueRock ...
• GB Sciences Granted US Patent for Cannabinoid-based Formulations for Parkinson’s May 7, 2020 GB Sciences has been granted a patent from the U.S. Patent and Trademark Office (USPTO) covering the use of its proprietary cannabinoid-containing complex mixtures for treating Parkinson’s disease, the company announced. GB Sciences is creating a pipeline of new medicines based on cannabinoids, the pharmacologically active compounds that give the cannabis plant its medical and recreational properties. The patent — number 10,653,640…
• Lilly to acquire gene therapy specialist, Prevail Therapeutics, in a deal worth US$1.04bn - BioPharma-Reporter.com December 15, 2020 Lilly to acquire gene therapy specialist, Prevail Therapeutics, in a deal worth US$1.04bn  BioPharma-Reporter.com
• Rockville biopharma’s ADHD drug emerges from the clinic with good news - Washington Business Journal December 23, 2020 Rockville biopharma’s ADHD drug emerges from the clinic with good news  Washington Business Journal
• AbbVie Is Mizuho’s Top Pick Among Large-Cap Biopharma Stocks - Barron's January 7, 2021 AbbVie Is Mizuho’s Top Pick Among Large-Cap Biopharma Stocks  Barron's
• Technology Has Broken Healthcare Barriers During the COVID-19 Pandemic December 29, 2020 COVID-19 has prompted clinicians to change how they deliver care and to reallocate resources toward the most urgent needs on a global scale.1 Patients with diseases ranging from Parkinson disease to chronic pain have been forced to wait for extended periods of time for necessary interventions and treatments. Consequently, many have experienced higher levels of pain, depression, and an overall…
• Global Roundup, Oct. 31 | BioSpace - BioSpace October 31, 2019 Global Roundup, Oct. 31 | BioSpace  BioSpace
• Procrastinator or Planner? At the Crossroads August 20, 2018 Are you by nature a planner or a procrastinator? As a clinical social worker in a PD Center of Excellence I work with people with Parkinson’s (PWP) and their care partners at critical crossroads of decision making, it is challenging to balance planning ahead versus staying focused in the present. My social work training and decades of experience help me…
• What’s New in Parkinson’s: December 2020 December 31, 2020 From tomatoes to live-streaming brain activity to genetic testing studies, news from the Parkinson’s field is as varied as it is encouraging this month. Here are some of the most important articles, podcasts, research, and living well stories happening as we wrap up 2020. Let us know if we missed anything important. Happy reading and happy new year! PARKINSON’S ARTICLES…